Cargando…

Complication of coronavirus disease 2019 during remission induction therapy against anti-MDA5 antibody-positive dermatomyositis

Detalles Bibliográficos
Autores principales:	Kogami, Masahiro, Suzuki, Satoshi, Nanjo, Yuta, Ikeda, Keigo, Tamura, Naoto, Sasaki, Shinichi, Morimoto, Shinji
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2020
Materias:	Letter to the Editor (Case report)
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7717435/ https://www.ncbi.nlm.nih.gov/pubmed/33336141 http://dx.doi.org/10.1093/rap/rkaa068

Ejemplares similares

Circulating plasma microRNA profiling in patients with polymyositis/dermatomyositis before and after treatment: miRNA may be associated with polymyositis/dermatomyositis
por: Hirai, Takuya, et al.
Publicado: (2018)

7. Anti-MDA5 associated dermatomyositis
por: Laverty, Ursula, et al.
Publicado: (2019)

Editorial: Anti-MDA5-Positive Dermatomyositis
por: Gono, Takahisa, et al.
Publicado: (2022)

Efficacy and safety of dose escalation of tofacitinib in refractory anti-MDA5 antibody-positive dermatomyositis
por: Ida, Tomoaki, et al.
Publicado: (2023)

Interstitial lung disease in clinically amyopathic dermatomyositis with and without anti-MDA-5 antibody: to lump or split?
por: Ikeda, Satoshi, et al.
Publicado: (2015)

Recurrence of anti-MDA5 antibody-positive clinically amyopathic dermatomyositis after long-term remission: A case report
por: Endo, Yushiro, et al.
Publicado: (2018)

Pneumomediastinum in MDA5-associated clinically amyopathic dermatomyositis
por: Kotsiou, Ourania S., et al.
Publicado: (2017)

Therapiealternativen bei amyopathischer MDA5-positiver Dermatomyositis
por: Schumacher, Falk, et al.
Publicado: (2023)

On the Nose: Anti-MDA-5 Dermatomyositis Manifesting as Perinasal Swelling
por: Molina, Emily, et al.
Publicado: (2022)

The PRINTO provisional definition of remission in juvenile dermatomyositis
por: Lazarevic, D, et al.
Publicado: (2011)

Management strategies for dermatomyositis during the coronavirus disease 2019 outbreak
por: Pi, Zixin, et al.
Publicado: (2020)

The Serum Ferritin Level Is Associated with the Treatment Responsivity for Rapidly Progressive Interstitial Lung Disease with Amyopathic Dermatomyositis, Irrespective of the Anti-MDA5 Antibody Level
por: Osawa, Takeshi, et al.
Publicado: (2017)

Treatment of MDA5-positive dermatomyositis complicated by gangrenous cholecystitis with tofacitinib
por: Luo, Man, et al.
Publicado: (2022)

Anti-MDA5 Amyopathic Dermatomyositis—A Diagnostic and Therapeutic Challenge
por: Bobirca, Anca, et al.
Publicado: (2022)

Clinical Features of Dermatomyositis/Polymyositis with Anti-MDA5 Antibody Positivity
por: Chen, Qiuhe, et al.
Publicado: (2022)

Subcutaneous Calcinosis in a Patient with Anti-MDA5 Positive Dermatomyositis
por: Hou, Ruihong, et al.
Publicado: (2021)

Performance of classification and diagnostic criteria for IgG4-related disease and comparison of patients with and without IgG4-related disease
por: Kogami, Masahiro, et al.
Publicado: (2023)

Recurrence of juvenile dermatomyositis 8 years after remission
por: Muramatsu, Ken, et al.
Publicado: (2016)

Remission of recalcitrant dermatomyositis following a chiropractic adjustment
por: Chu, Eric C. P., et al.
Publicado: (2019)

Anti-MDA5 Antibodies in a Large Mediterranean Population of Adults with Dermatomyositis
por: Labrador-Horrillo, Moises, et al.
Publicado: (2014)

MDA5-positive dermatomyositis: an uncommon entity in Europe with variable clinical presentations
por: Parronchi, Paola, et al.
Publicado: (2015)

Anti-MDA5 antibody-positive dermatomyositis presenting as unilateral eyelid edema
por: Chen, Lauren, et al.
Publicado: (2020)

Anti-MDA-5 Dermatomyositis With Development of Drug-Mediated Necrolytic Skin Lesions
por: Case, Robert A., et al.
Publicado: (2020)

Dermatomyositis With Anti-MDA5 Antibodies: Bioclinical Features, Pathogenesis and Emerging Therapies
por: Nombel, Anaïs, et al.
Publicado: (2021)

Seasonal Effect on Disease Onset and Presentation in Anti-MDA5 Positive Dermatomyositis
por: So, Ho, et al.
Publicado: (2022)

Pathogenesis of anti-melanoma differentiation-associated gene-5 (MDA5) dermatomyositis
por: Weng, Chenghua, et al.
Publicado: (2022)

Cardiac involvement in anti-MDA5 dermatomyositis: a case-based review
por: Quintero-González, Diana C., et al.
Publicado: (2022)

Case Report: Anti-MDA-5 dermatomyositis in a resource-limited setting
por: Risal, Ujjwol, et al.
Publicado: (2023)

Phenotypes of Peripheral Blood Lymphocytes and Cytokine Expression in Polymyositis and Dermatomyositis before Treatment and after Clinical Remission
por: Shimojima, Yasuhiro, et al.
Publicado: (2012)

Transcriptomic profiling and longitudinal study reveal the relationship of anti-MDA5 titer and type I IFN signature in MDA5+ dermatomyositis
por: Wang, Yan, et al.
Publicado: (2023)

Anti-MDA5 antibody as a potential diagnostic and prognostic biomarker in patients with dermatomyositis
por: Li, Liubing, et al.
Publicado: (2017)

Understanding and managing anti-MDA 5 dermatomyositis, including potential COVID-19 mimicry
por: Mehta, Pankti, et al.
Publicado: (2021)

Painless Panniculitis upon the Treatment of Clinically Amyopathic Dermatomyositis with Anti-MDA5 Antibody
por: Kishida, Dai, et al.
Publicado: (2021)

Macrophage activation syndrome in MDA5 antibody-positive dermatomyositis and COVID-19 infection
por: Keshtkarjahromi, Marzieh, et al.
Publicado: (2021)

Neutrophil-to-lymphocyte ratio is a predictive marker for anti-MDA5 positive dermatomyositis
por: Liu, Tao, et al.
Publicado: (2022)

Dermatomyositis Which Was Double Positive for Anti-MDA5 and Anti-ARS Antibodies That Was Successfully Treated by Intensive Immunosuppressive Therapy
por: Hama, Satoshi, et al.
Publicado: (2022)

Hypomyopathic Dermatomyositis Presenting with Idiopathic CD4 T-lymphocytopenia and Delayed Anti-MDA5 Positivity
por: Mijares, Maria C, et al.
Publicado: (2019)

Management of MDA-5 antibody-positive dermatomyositis with interstitial lung disease—an Auckland case series
por: Dick, Michael, et al.
Publicado: (2021)

Mitochondrial morphology and MAVS‐IFN1 signaling pathway in muscles of anti‐MDA5 dermatomyositis
por: Jiang, Yanyan, et al.
Publicado: (2021)

Anti-MDA5 Antibody-Associated Clinically Amyopathic Dermatomyositis: Case Report and Literature Review
por: Kersey, Cooper B., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_sstro0g5erktfuedfvg961eo3h